JPWO2023190820A5 - - Google Patents
Info
- Publication number
- JPWO2023190820A5 JPWO2023190820A5 JP2024512766A JP2024512766A JPWO2023190820A5 JP WO2023190820 A5 JPWO2023190820 A5 JP WO2023190820A5 JP 2024512766 A JP2024512766 A JP 2024512766A JP 2024512766 A JP2024512766 A JP 2024512766A JP WO2023190820 A5 JPWO2023190820 A5 JP WO2023190820A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- sequence shown
- seq
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022055606 | 2022-03-30 | ||
| PCT/JP2023/013069 WO2023190820A1 (ja) | 2022-03-30 | 2023-03-30 | 抗ＣＫ２α抗体又はその断片 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023190820A1 JPWO2023190820A1 (enExample) | 2023-10-05 |
| JPWO2023190820A5 true JPWO2023190820A5 (enExample) | 2026-04-02 |
Family
ID=88202747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512766A Pending JPWO2023190820A1 (enExample) | 2022-03-30 | 2023-03-30 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240376227A1 (enExample) |
| EP (1) | EP4403581A4 (enExample) |
| JP (1) | JPWO2023190820A1 (enExample) |
| WO (1) | WO2023190820A1 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003093056A (ja) * | 2001-09-26 | 2003-04-02 | Japan Science & Technology Corp | ｐ５３のＳｅｒ４６をリン酸化する酵素 |
| CA2501719C (en) * | 2002-08-06 | 2013-02-05 | Toray Industries, Inc. | Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| WO2011041785A1 (en) * | 2009-10-02 | 2011-04-07 | Cylene Pharmaceuticals, Inc. | Biomarkers for predicting the sensitivity and response of protein kinase ck2-mediated diseases to ck2 inhibitors |
| WO2012003493A2 (en) * | 2010-07-01 | 2012-01-05 | The Regents Of The University Of California | Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use |
| EP2472263A1 (en) * | 2011-01-03 | 2012-07-04 | Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives | Methods for the prognostic assessment of breast cancer |
| EP4083627A4 (en) | 2019-12-25 | 2024-01-17 | Hoshi General Hospital, a Public Interest Incorporated Foundation | PROGNOSTIC BIOMARKER OF CANCER |
| JP2022055606A (ja) | 2020-09-29 | 2022-04-08 | 株式会社 Ｍｔｓ雪氷研究所 | プログラム及び開口部装置 |
-
2023
- 2023-03-30 JP JP2024512766A patent/JPWO2023190820A1/ja active Pending
- 2023-03-30 WO PCT/JP2023/013069 patent/WO2023190820A1/ja not_active Ceased
- 2023-03-30 US US18/579,662 patent/US20240376227A1/en active Pending
- 2023-03-30 EP EP23780828.2A patent/EP4403581A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007526233A5 (enExample) | ||
| JP2009541204A5 (enExample) | ||
| EP3073268A1 (en) | Biomarker panel for diagnosing cancer | |
| US12174195B2 (en) | Compositions and methods for assessing the risk of cancer occurrence | |
| JP2020510409A5 (enExample) | ||
| JP6081699B2 (ja) | Ｉｌ−２８ｂの分析方法 | |
| EP4372003A1 (en) | Antibody combination against regenerating islet-derived protein 1? and detection kit comprising same | |
| CN104530234A (zh) | 检测人vegf的组合试剂、试剂盒及其使用方法 | |
| EP3094973B1 (en) | Biomarkers | |
| CN103842823B (zh) | 用于胸膜间皮瘤患者的早期发现的分子标志物及其表达分析方法 | |
| JPWO2023190820A5 (enExample) | ||
| KR20180041467A (ko) | 코어-푸코실화 알파-페토프로테인에 특이적으로 결합하는 항체를 이용한 면역 분석법 | |
| CN106814192B (zh) | 用于肝癌检测的标志物组合及检测试剂盒 | |
| US10001492B2 (en) | Method for diagnosing inflammatory bowel disease | |
| EP2791682B1 (en) | Assay | |
| WO2012067267A1 (en) | TESTING METHOD USING ANTI-C1q MONOCLONAL ANTIBODY | |
| JP2018516876A (ja) | Ｉｇｆ−１ｒ抗体および癌の診断のためのその使用 | |
| KR20160114716A (ko) | 악성 신생물 질환의 검출을 위한 조성물 및 방법 | |
| US20240117070A1 (en) | Recombinant antibodies, kits comprising the same, and uses thereof | |
| JPWO2023132333A5 (enExample) | ||
| CA3009768C (en) | Compositions and methods for assessing the risk of cancer occurrence | |
| CN119569883A (zh) | 抗pgrmc1单克隆抗体及其作为肾上腺皮质癌诊断剂中的应用 | |
| RU2013131236A (ru) | Иммуноанализ белка кофилина 1 | |
| EP3364188B1 (en) | Blood biomarker for use in evaluation of effect of drug therapy on kidney cancer | |
| CN119684462A (zh) | 抗癌胚抗原单克隆抗体的制备方法及应用 |